Literature DB >> 8953592

The NCCN Guidelines Development Program.

R J Winn1, W Botnick, N Dozier.   

Abstract

The National Comprehensive Cancer Network (NCCN) has begun a program for the development of comprehensive clinical practice guidelines for the management of the most common tumors. The NCCN guidelines reflect a process of consensus that relies on evaluation of the evidence and structured feedback. The guidelines are designed to reflect clinical decision-making, and attempt to deal with the complexity of managing cancer. The initial guidelines effort has yielded eight guidelines for adult cancers and three for pediatric cancers. The guidelines are set up in algorithm format. The NCCN members believe that clinical trials are always an appropriate form of patient management, and that the inclusion of a patient in a clinical trial is preferred at every decision point in the algorithm.

Entities:  

Mesh:

Year:  1996        PMID: 8953592

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  4 in total

Review 1.  An informatics blueprint for healthcare quality information systems.

Authors:  Joyce C Niland; Layla Rouse; Douglas C Stahl
Journal:  J Am Med Inform Assoc       Date:  2006-04-18       Impact factor: 4.497

2.  Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing.

Authors:  Zoë P Mackay; Dmitry Dukhovny; Kathryn A Phillips; Alan H Beggs; Robert C Green; Richard B Parad; Kurt D Christensen
Journal:  Value Health       Date:  2020-03-20       Impact factor: 5.725

3.  Selecting high priority quality measures for breast cancer quality improvement.

Authors:  Michael J Hassett; Melissa E Hughes; Joyce C Niland; Rebecca Ottesen; Stephen B Edge; Michael A Bookman; Robert W Carlson; Richard L Theriault; Jane C Weeks
Journal:  Med Care       Date:  2008-08       Impact factor: 2.983

4.  A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients.

Authors:  Michael J Pishvaian; Edik M Blais; R Joseph Bender; Shruti Rao; Simina M Boca; Vincent Chung; Andrew E Hendifar; Sam Mikhail; Davendra P S Sohal; Paula R Pohlmann; Kathleen N Moore; Kai He; Bradley J Monk; Robert L Coleman; Thomas J Herzog; David D Halverson; Patricia DeArbeloa; Emanuel F Petricoin; Subha Madhavan
Journal:  JAMIA Open       Date:  2019-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.